Correction to: Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs

Detalles Bibliográficos
Autores principales: de Salazar Alcalá, Andrea García, Gioda, Lucile, Dehman, Alia, Beugnet, Frederic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796375/
https://www.ncbi.nlm.nih.gov/pubmed/31619253
http://dx.doi.org/10.1186/s12917-019-2116-1
_version_ 1783459571959857152
author de Salazar Alcalá, Andrea García
Gioda, Lucile
Dehman, Alia
Beugnet, Frederic
author_facet de Salazar Alcalá, Andrea García
Gioda, Lucile
Dehman, Alia
Beugnet, Frederic
author_sort de Salazar Alcalá, Andrea García
collection PubMed
description
format Online
Article
Text
id pubmed-6796375
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67963752019-10-21 Correction to: Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs de Salazar Alcalá, Andrea García Gioda, Lucile Dehman, Alia Beugnet, Frederic BMC Vet Res Correction BioMed Central 2019-10-17 /pmc/articles/PMC6796375/ /pubmed/31619253 http://dx.doi.org/10.1186/s12917-019-2116-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Correction
de Salazar Alcalá, Andrea García
Gioda, Lucile
Dehman, Alia
Beugnet, Frederic
Correction to: Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs
title Correction to: Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs
title_full Correction to: Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs
title_fullStr Correction to: Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs
title_full_unstemmed Correction to: Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs
title_short Correction to: Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs
title_sort correction to: assessment of the efficacy of firocoxib (previcox®) and grapiprant (galliprant®) in an induced model of acute arthritis in dogs
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796375/
https://www.ncbi.nlm.nih.gov/pubmed/31619253
http://dx.doi.org/10.1186/s12917-019-2116-1
work_keys_str_mv AT desalazaralcalaandreagarcia correctiontoassessmentoftheefficacyoffirocoxibprevicoxandgrapiprantgalliprantinaninducedmodelofacutearthritisindogs
AT giodalucile correctiontoassessmentoftheefficacyoffirocoxibprevicoxandgrapiprantgalliprantinaninducedmodelofacutearthritisindogs
AT dehmanalia correctiontoassessmentoftheefficacyoffirocoxibprevicoxandgrapiprantgalliprantinaninducedmodelofacutearthritisindogs
AT beugnetfrederic correctiontoassessmentoftheefficacyoffirocoxibprevicoxandgrapiprantgalliprantinaninducedmodelofacutearthritisindogs

Ejemplares similares